Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03638843 · ClinicalTrials.gov registry record · NA
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03638843: Completed NA study, sponsored by Johns Hopkins University.
NCT03638843 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03638843, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Rapid metabolic improvements seen with sleeve gastrectomy are likely a result of changes in gastric origin. The gastric mucosa is an endocrine organ that regulates satiation pathways and is a complex regulator of food intake as well as lipid and glucose metabolism. This study aims to assess the efficacy and safety of endoscopic selective gastric mucosal devitalization (GMD) for the management of obesity and its related comorbidities.
Interventions
- PROCEDURE Gastric mucosal devitalization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2021-07-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03638843
The ClinicalTrials.gov registry entry for NCT03638843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gastric mucosal devitalization is the first listed.
NCT03638843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03638843 about?
NCT03638843 is a clinical study titled "Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2". Rapid metabolic improvements seen with sleeve gastrectomy are likely a result of changes in gastric origin. The gastric mucosa is an endocrine organ that regulates satiation pathways and is a complex regulator of food intake as well as lipid and glucose metabolism. This study aims to assess the effi...
What is the current status of trial NCT03638843?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-09-25. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT03638843?
The interventions under investigation include: Gastric mucosal devitalization (PROCEDURE).
Who is sponsoring clinical trial NCT03638843?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.